PharmEconomy Ltd

Company Description

PharmEconomy is a pricing and commercial access consultancy for the pharmaceuticals industry that enables successful navigation of the increasingly complex commercial access environment in the UK, with the aim of gaining and maintaining patient access for medicines at a price that is beneficial to both pharmaceutical companies and the NHS. Coupled with extensive experience in multiple disease areas, branded pharmaceuticals including novel technologies such as CAR-T and gene therapy, PharmEconomy's purpose is to successfully pilot your route to market across the entire lifecycle from pre-launch to loss of patent or divestment.PharmEconomy has strong relationships with key stakeholders at NICE, NHSE and within the devolved nations to enable early engagement that can deliver sustainable solutions to pricing your brands, providing value, affordability and transactability to the NHS. Early engagement can prevent multiple rounds of negotiations, therefore gaining a positive appraisal as soon as possible after licence approval. We are practiced in negotiations with NHS England, and the devolved UK countries in innovative pricing schemes including complex PAS, outcome-based deals, capping schemes and portfolio offerings as well as simple free of charge and rebate schemes. PharmEconomy is experienced in developing commercial strategies to maintain sales and branded market access for brands that face patent expiry and legal challenge from generics. Using extensive expertise built over many years, PharmEconomy can advise on methods to protect brand loyalty.If you have a commercial access or pricing challenge get in touch to see if PharmEconomy can deliver the road-map to a more collaborative, streamlined approach.email: MandyYouds@PharmEconomy.com